Albios Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.14 M
- Revenue Growth 13.16%
- Profit Growth 115.72%
- Ebitda 391.30%
- Net Worth 36.12%
- Total Assets 62.28%
About Albios Lifesciences
Albios Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2011 and has a history of 14 years. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Allegens Lifescience Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.14 M.
Jayprakash Mishra and Anubhav Dwivedi serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2011PTC064055
- Company No.
064055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Albios Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anubhav Dwivedi  | Additional Director | 04-Aug-2016 | Current |
| Jayprakash Mishra | Director | 10-Mar-2011 | Current |
Financial Performance of Albios Lifesciences.
Albios Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.16% increase. The company also saw a substantial improvement in profitability, with a 115.72% increase in profit. The company's net worth Soared by an impressive increase of 36.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albios Lifesciences?
In 2023, Albios Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novum Therapeutics Private LimitedJayprakash Mishra is a mutual person
- Confy Media Private Limited
Anubhav Dwivedi is a mutual person
Charges (Loans)
₹9.14 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.71 Cr
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2022 | Hdfc Bank Limited | ₹2.00 M | Open |
| 03 Apr 2021 | Axis Bank Limited | ₹7.15 M | Open |
How Many Employees Work at Albios Lifesciences?
Unlock and access historical data on people associated with Albios Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albios Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albios Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
